Showing 281-290 of 834 results for "".
Formulation Matters: New Data Demonstrates Qlosi is Pupil Selective
https://modernod.com/mod-issues/2025-nov-dec/formulation-matters-new-data-demonstrates-qlosi-is-pupil-selective/54305/In a study, which utilized images captured with a specialized anterior-segment OCT device, pilocarpine was shown to have a dose-dependent effect on pupil diameter.One to Watch: Nicole Harris, OD
https://modernod.com/mod-issues/2024-jan-feb/one-to-watch-nicole-harris-od/38755/The AlloFlo™ Uveo
https://modernod.com/articles/visionary-breakthroughs/the-alloflosupsup-uveo/39824/Unlocking the uveoscleral pathway post-MIGS.Your Great-Grandkids May Not Live Past 100
https://modernod.com/articles/significant-findings/your-great-grandkids-may-not-live-past-100/37807/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatIt’s Your Eye Color, Deal With It
https://modernod.com/articles/significant-findings/its-your-eye-color-deal-with-it/37802/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatNew Glaucoma Device Implanted in First Human
https://modernod.com/articles/significant-findings/new-glaucoma-device-implanted-in-first-human/37801/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatDry Eye, and LLLT, and Periodontitis, Oh My!
https://modernod.com/articles/significant-findings/dry-eye-and-lllt-and-periodontitis-oh-my/37798/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatThis Week: Josh’s Refractive Surgery
https://modernod.com/articles/significant-findings/this-week-joshs-refractive-surgery/37785/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatAre We Close to Transplanting Whole Human Eyes?
https://modernod.com/articles/significant-findings/are-we-close-to-transplanting-whole-human-eyes/37776/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatMore Virtual CE Please
https://modernod.com/articles/significant-findings/more-virtual-ce-please/37761/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat